Company / EPS (Diluted)
Ernexa Therapeutics Inc. EPS (Diluted) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$48.96
FY2025
5-year range
-$48.96 / -$0.10
FY2021-FY2025
Trend
-1100.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -1100% YoY in FY2025, a notable deviation from the 9-year average annual change of -1048%.
Based on SEC 10-K filings.
-48.96 in FY2025.
Declined from $-8.06 to $-48.96 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 1100.0% year-over-year.
- Peak eps (diluted) was recorded in FY2014.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$48.96 | -1100.0% |
| FY2024 | -$4.08 | +49.4% |
| FY2023 | -$8.06 | -1019.4% |
| FY2020 | -$0.72 | -620.0% |
| FY2019 | -$0.10 | +77.8% |
| FY2018 | -$0.45 | +70.8% |
| FY2017 | -$1.54 | +60.8% |
| FY2016 | -$3.93 | -6450.0% |
| FY2015 | -$0.06 | -500.0% |
| FY2014 | -$0.01 | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026